Global Peptide Synthesis Market to Surpass US$ 546.3 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)--Jan 11, 2021--

According to Coherent Market Insights, the global peptide synthesis market is estimated to be valued at US$ 348.9 million in 2020 and is expected to exhibit a CAGR of 6.6% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Peptide Synthesis Market:

Key trends in the market include rising incidence of chronic diseases such as metabolic disorders, cardiovascular disorders, respiratory disorders, infectious diseases, and others, rising number of product approvals and launches, and ongoing research and development for peptide synthesis.

Market players are focusing on product launches, which is expected to drive the market growth. For instance, in December 2020, CSBio, focuses in the area of peptide synthesizers and custom peptides, launched CSBio II, a fully featured automated peptide synthesizer. This product is easy to operate and is used for manufacturing peptides in 50 mg to 500 mg scale.

Moreover, increasing cases of chronic diseases such as cardiovascular disorders and others is expected to boost the market growth. For instance, according to an article published by the National Center for Biotechnology Information (NCBI) by the Global Burden of Disease (GBD), in 2020, the prevalence rate of ischemic heart disease was 1,655 per 100,000 population, and is expected to exceed 1,845 by 2030.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4336

Key Market Takeaways:

The global peptide synthesis market is expected to exhibit a CAGR of 6.6% during the forecast period, owing to rising incidence of respiratory diseases. For instance, according to an article published by the World Health Organization in May 2020, the most common chronic disease among children worldwide and over 339 million people are living with asthma in 2020. Similarly, according to the same source, over 80% of asthma-related deaths occur in low and lower-middle income countries.

Key players in the market are focusing on inorganic strategies such as acquisitions is expected to propel the market growth during the forecast period. For instance, in May 2019, Merck, a leading science and technology company acquired Grzybowski Scientific Inventions (GSI), a company engaged in evolutionary computer-aided retro-synthesis tool, Chematica. With this acquisition Merck expanded its chemical synthesis portfolio.

Competitive Landscape:

Key players operating in the global peptide synthesis market include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4336

Market Segmentation:

Global Peptide Synthesis Market, By Product:
- Reagents & Consumables
- Equipment
  - Peptide Synthesizers
  - Lyophilizers
  - Chromatography Equipment

Global Peptide Synthesis Market, By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant

Global Peptide Synthesis Market, By Application:
- Therapeutics
  - Metabolic Disorders
  - Cardiovascular Disorders
  - Respiratory Disorders
  - Infectious Diseases
  - Others
- Diagnosis
- Research

Global Peptide Synthesis Market, By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
Global Peptide Synthesis Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country:
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa

Related Market Intelligence Reports:

Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210111005672/en/

CONTACT: Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:

US:+1-206-701-6702

UK:+44-020-8133-4027

Japan:+81-050-5539-1737

India:+91-848-285-0837

Email:[email protected]

Website:https://www.coherentmarketinsights.com

KEYWORD: WASHINGTON UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: INFECTIOUS DISEASES PHARMACEUTICAL HEALTH CARDIOLOGY

SOURCE: Coherent Market Insights

PUB: 01/11/2021 10:08 AM/DISC: 01/11/2021 10:09 AM

http://www.businesswire.com/news/home/20210111005672/en